Colgate-Palmolive (NYSE:CL) reported quarterly earnings of $0.80 per share which beat the analyst consensus estimate of $0.79 by 1.27 percent. This is a 6.67 percent increase over earnings of $0.75 per share from the same period last year. The company reported quarterly sales of $4.34 billion which beat the analyst consensus estimate of $4.25 billion by 2.21 percent. This is a 6.03 percent increase over sales of $4.10 billion the same period last year.
These 18 Clinical Trials Could Shape The Future Of The Psychedelics Industry
In the nascent industry of medical psychedelics, drug development is the name of the game.
This subset of biotech, poised to become a $100 billion industry according to Canaccord Genuity, bases its success on the regulation and approval of scheduled psychoactive substances for mental health and other health indications.
